Ocean Biomedical partners to bring hepatitis B drug to human trials


The goal of the new joint venture is to develop treatments for cancer and infectious diseases using T cell-based immunotherapies.

Previous PBMs, drug costs and workforce: Top issues plaguing pharmacists, according to Tennessee Pharmacists Association CEO
Next Recreational marijuana in Ohio: Supporters and opponents make their case